Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Post by threefiftynineon Jun 20, 2020 8:41am
235 Views
Post# 31172463

--A WELL ORCHESTRATED PRIVATE PLACEMENT---

--A WELL ORCHESTRATED PRIVATE PLACEMENT---
Now the facts remain that this company is on the verge of having more money in the bank than in their history. Mixing a few cocktails in a lab is one thing. Having hundreds of HUMANS coming in to the SOURASKY MED CENTRE to be humungous rats --now that's another thing eh?---PHASE1 is so important here as it makes PHASE2 and 3 in the fall to 2021 a very exciting investment. Ignore this experiment at your financial peril---.09 cents lol---- i really do see why bligicka is ticked off......Now, in closing ,---Has the CEO, DAVID GOREN, splashed any cash yet from his wallet ??????????? because that is the catalyst you keep your eyes on . Maybe next week eh?
<< Previous
Bullboard Posts
Next >>